| 0 (0%) | 12-05 10:09 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 17.05 | 1-year : | 19.91 |
| Resists | First : | 14.6 | Second : | 17.05 |
| Pivot price | 13.84 |
|||
| Supports | First : | 13.74 | Second : | 13.21 |
| MAs | MA(5) : | 13.91  |
MA(20) : | 13.9 |
| MA(100) : | 13.64 |
MA(250) : | 0 | |
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 65.4 |
D(3) : | 60.5 |
| RSI | RSI(14): 51.6 |
|||
| 52-week | High : | 15.51 | Low : | 9.46 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ AES ] has closed below upper band by 21.9%. Bollinger Bands are 63.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 7 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 14.04 - 14.13 | 14.13 - 14.21 |
| Low: | 13.49 - 13.58 | 13.58 - 13.68 |
| Close: | 13.78 - 13.92 | 13.92 - 14.07 |
Fri, 05 Dec 2025
This Albemarle Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday - Benzinga
Fri, 05 Dec 2025
New Analyst Forecast: $AES Given $18 Price Target - Quiver Quantitative
Fri, 05 Dec 2025
Stoke Therapeutics, Inc. and Biogen Present Data on Zorevunersen at AES 2025 - TradingView
Fri, 05 Dec 2025
Argus Upgrades AES to Buy From Hold, Price Target is $18 - marketscreener.com
Fri, 05 Dec 2025
AES (AES) Receives Upgrade to Buy Rating by Argus Research Today - GuruFocus
Fri, 05 Dec 2025
Burkina Faso’s Traoré becomes first AES leader to receive new regional identity card - Business Insider Africa
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 712 (M) |
| Shares Float | 708 (M) |
| Held by Insiders | 0.4 (%) |
| Held by Institutions | 90.3 (%) |
| Shares Short | 24,690 (K) |
| Shares Short P.Month | 26,020 (K) |
| EPS | 1.51 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 5.42 |
| Profit Margin | 8.7 % |
| Operating Margin | 20.5 % |
| Return on Assets (ttm) | 2.2 % |
| Return on Equity (ttm) | 5.1 % |
| Qtrly Rev. Growth | 1.8 % |
| Gross Profit (p.s.) | 2.93 |
| Sales Per Share | 16.97 |
| EBITDA (p.s.) | 4.5 |
| Qtrly Earnings Growth | 25.2 % |
| Operating Cash Flow | 3,910 (M) |
| Levered Free Cash Flow | -3,690 (M) |
| PE Ratio | 9.21 |
| PEG Ratio | 0 |
| Price to Book value | 2.57 |
| Price to Sales | 0.82 |
| Price to Cash Flow | 2.55 |
| Dividend | 0.18 |
| Forward Dividend | 0 |
| Dividend Yield | 1.2% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|